Internal Medicine

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.

The findings also showed that large bedded hospitals trended towards higher clostridium difficile infection incidence and mortality rates.

A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.

Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.

A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.

New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.

New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.

Research shows dupilumab remains effective in EoE for up to 2 years.

A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.

In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.

Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.

Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.

The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.

In data presented during Kidney Week, researchers find the risk of developed an acute kidney injury increased in both sickle cell trail and sickle cell disease patients.

Compared with prophylaxis anticoagulation, full dose anticoagulation provided a greater survival benefit to those in a predominantly black population.

A majority of the patients included in the analysis (93%) indicated they had uncontrolled asthma.

Precision medicine could have a major impact in ADHD.

According to recommendations, electronic media should actively engage in efforts to address the prevention and management of sickle cell disease.

The Full Field Peripheral Blood Smear application addresses shortcomings of current digital solutions.

Dr. Albert discusses how preventative care and access to health care are important in closing health discrepancies.

Dr. Albert discusses some ways to close the racial outcome gaps in cardiology.

A common theme among clinical staff focus groups was the pervasiveness of systemic and social barriers to addressing basic needs in children with sickle cell disease.

Stem cell transplantation can be a curative treatment for sickle cell disease, but there is some safety risks.